Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Stat5 in breast cancer: potential oncogenic activity coincides with positive prognosis for the disease
Itamar Barash
Carcinogenesis (2012) Vol. 33, Iss. 12, pp. 2320-2325
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Crosstalk between PRLR and EGFR/HER2 Signaling Pathways in Breast Cancer
Raghuveer Kavarthapu, Rajakumar Anbazhagan, Maria Dufau
Cancers (2021) Vol. 13, Iss. 18, pp. 4685-4685
Open Access | Times Cited: 65
Prolactin levels and breast cancer risk by tumor expression of prolactin-related markers
Cassandra A. Hathaway, Megan S. Rice, Laura C. Collins, et al.
Breast Cancer Research (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 27
Regulation of cell signaling pathways by dietary agents for cancer prevention and treatment
Manoj K. Pandey, Subash C. Gupta, Ali Nabavizadeh, et al.
Seminars in Cancer Biology (2017) Vol. 46, pp. 158-181
Closed Access | Times Cited: 68
Involvement of STAT5 in Oncogenesis
Clarissa Esmeralda Halim, Shuo Deng, Mei Shan Ong, et al.
Biomedicines (2020) Vol. 8, Iss. 9, pp. 316-316
Open Access | Times Cited: 65
Oncogenic STAT Transcription Factors as Targets for Cancer Therapy: Innovative Strategies and Clinical Translation
Weiyuan Wang, Melanie Cristina Lopez McDonald, Rajashree Hariprasad, et al.
Cancers (2024) Vol. 16, Iss. 7, pp. 1387-1387
Open Access | Times Cited: 7
N-myc downstream-regulated gene 2 (NDRG2) suppresses the epithelial–mesenchymal transition (EMT) in breast cancer cells via STAT3/Snail signaling
Myung-Jin Kim, Ji‐Hyun Lim, Young Yang, et al.
Cancer Letters (2014) Vol. 354, Iss. 1, pp. 33-42
Open Access | Times Cited: 66
FYN promotes mesenchymal phenotypes of basal type breast cancer cells through STAT5/NOTCH2 signaling node
Ga-Hang Lee, Ki-Chun Yoo, Yoojeong An, et al.
Oncogene (2018) Vol. 37, Iss. 14, pp. 1857-1868
Closed Access | Times Cited: 58
Mammalian Species-Specific Resistance to Mammary Cancer
Itamar Barash
Journal of Mammary Gland Biology and Neoplasia (2025) Vol. 30, Iss. 1
Open Access
Sophoraflavanone G induces apoptosis of human cancer cells by targeting upstream signals of STATs
Byung‐Hak Kim, Cheolhee Won, Yun-Han Lee, et al.
Biochemical Pharmacology (2013) Vol. 86, Iss. 7, pp. 950-959
Closed Access | Times Cited: 32
Diagnostic utility of phosphorylated signal transducer and activator of transcription 5 immunostaining in the diagnosis of mammary analogue secretory carcinoma of the salivary gland: A comparative study of salivary gland cancers
Akihiko Kawahara, Tomoki Taira, Hideyuki Abe, et al.
Cancer Cytopathology (2015) Vol. 123, Iss. 10, pp. 603-611
Open Access | Times Cited: 32
Exome Analysis Reveals Differentially Mutated Gene Signatures of Stage, Grade and Subtype in Breast Cancers
You Li, Xiaosheng Wang, Suleyman Vural, et al.
PLoS ONE (2015) Vol. 10, Iss. 3, pp. e0119383-e0119383
Open Access | Times Cited: 27
Expression and prognostic role of STAT5a across cancer types
Christine Maninang, Jinghong Li, Willis X. Li
Bioscience Reports (2023) Vol. 43, Iss. 8
Open Access | Times Cited: 5
Low UBE4B expression increases sensitivity of chemoresistant neuroblastoma cells to EGFR and STAT5 inhibition
Kimiya Memarzadeh, David J. Savage, Andrew J. Bean
Cancer Biology & Therapy (2019) Vol. 20, Iss. 12, pp. 1416-1429
Open Access | Times Cited: 14
Genomic Mutations of the STAT5 Transcription Factor Are Associated with Human Cancer and Immune Diseases
Ui-Jin Kim, Ha Youn Shin
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11297-11297
Open Access | Times Cited: 8
STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice
Doris Kaltenecker, Madeleine Themanns, Kristina M. Mueller, et al.
Cytokine (2018) Vol. 124, pp. 154573-154573
Open Access | Times Cited: 14
Expression of STAT5, COX-2 and PIAS3 in Correlation with NSCLC Histhopathological Features
Dorota Pastuszak‐Lewandoska, Daria Domańska, Karolina H. Czarnecka, et al.
PLoS ONE (2014) Vol. 9, Iss. 8, pp. e104265-e104265
Open Access | Times Cited: 13
FRA2 Is a STAT5 Target Gene Regulated by IL-2 in Human CD4 T Cells
Aradhana Rani, Roseanna Greenlaw, Manohursingh Runglall, et al.
PLoS ONE (2014) Vol. 9, Iss. 2, pp. e90370-e90370
Open Access | Times Cited: 13
Prolactin/androgen-inducible carboxypeptidase-D increases with nitrotyrosine and Ki67 for breast cancer progression in vivo, and upregulates progression markers VEGF-C and Runx2 in vitro
Lynn N. Thomas, Emily R. Chedrawe, Penelope J. Barnes, et al.
Breast Cancer Research and Treatment (2017) Vol. 164, Iss. 1, pp. 27-40
Closed Access | Times Cited: 13
Oncogenic STAT Transcription Factors as Targets for Cancer Therapy: Innovative Strategies and Clinical Translation
Weiyuan Wang, Melanie Cristina Lopez McDonald, Rajashree Hariprasad, et al.
(2024)
Open Access | Times Cited: 1
Phosphoinositide-3-Kinase Enhancers, PIKEs: Their Biological Functions and Roles in Cancer.
Weijuan Jia, Yi Feng, Andrew J. Sanders, et al.
PubMed (2016) Vol. 36, Iss. 3, pp. 1103-9
Closed Access | Times Cited: 10
Luminal STAT5 mediates H2AX promoter activity in distinct population of basal mammary epithelial cells
Moshe Reichenstein, Gat Rauner, Shenhav Hanna Kfir, et al.
Oncotarget (2016) Vol. 7, Iss. 27, pp. 41781-41797
Open Access | Times Cited: 10
Design, synthesis, and biological evaluation of benzo[b]thiophene 1,1‐dioxide derivatives as potent STAT3 inhibitors
Wenzhen Li, Huizhi Xi, Yijie Wang, et al.
Chemical Biology & Drug Design (2021) Vol. 98, Iss. 5, pp. 835-849
Closed Access | Times Cited: 10
Influence of Systemic Therapy on the Expression and Activity of Selected STAT Proteins in Prostate Cancer Tissue
Celina Ebersbach, Alicia-Marie K. Beier, Pia Hönscheid, et al.
Life (2022) Vol. 12, Iss. 2, pp. 240-240
Open Access | Times Cited: 5
Phospho-STAT5B Expression Is a Prognostic Marker for Merkel Cell Carcinoma
Taku Fujimura, Sadanori Furudate, YUMI KAMBAYAHSI, et al.
Anticancer Research (2017) Vol. 37, Iss. 5, pp. 2335-2341
Open Access | Times Cited: 6
In-depth analysis of the interplay between oncogenic mutations and NK cell-mediated cancer surveillance in solid tumors
Cecilia Pesini, Laura Artal, J. Bernal, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top